Skip to main content
. Author manuscript; available in PMC: 2022 Apr 15.
Published in final edited form as: Neurosurg Focus. 2022 Feb;52(2):E9. doi: 10.3171/2021.11.FOCUS21571

Figure 2.

Figure 2.

Examples of different approaches to analyzing multiomics data. (2A) Clustering methods can be used to assess patient-to-patient and tissue-to-tissue variation in musculoskeletal tissue samples from patients with DDD, (2B) Network methods can be used to assess immune signaling pathways that are active in patients with DDD, (2C) Overrepresentation analyses can be used to detect signatures of resistance to OV therapy in GBM. Figure 2A and 2B used with permission form Bydon et al, 20202.